Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19 - update 27 September 2022

These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.

Auteurs